Share Price.com
Share Search

Shield Thera Share News


Share Price: 112.00   Bid / Ask: 111.00 / 113.00   High: 113.00   Low: 111.00



Shield Therapeutics Plc Ord 1.5P Share News

UK stocks open 1.1% lower as trade tensions escalate


3 Jun '19
... UK stocks opened substantially lower on Monday after oil and mining stocks were hurt by growing fears about the health of US trade relationships with China and Mexico.

At 0848, the FTSE 100 was down 80.28 points, or 1.1%, at 7.082.24.

Construction company Kier pluned 38% after Read More...

HeadlineDate
UK stocks open 1.1% lower as trade tensions escalate3 Jun '19
Shield Therapeutic says Teva Pharmaceutical has filed appeal over patent ruling3 Jun '19
Broker Forecast - finnCap issues a broker note on Shield Therapeutics Plc14 May '19
Shield Therapeutics iron deficiency treatment gets Swiss regulatory nod24 Apr '19
Director Deals - Shield Therapeutics Plc (STX)17 Apr '19
Broker Forecast - Peel Hunt issues a broker note on Shield Therapeutics Plc12 Mar '19
Shield Therapeutics records positive results from trial of iron deficiency treatment4 Mar '19
Broker Forecast - Liberum Capital issues a broker note on Shield Therapeutics Plc19 Feb '19
Shield Therapeutics reports promising results from iron-deficiency treatment study29 Jan '19
Shield Therapeutics appoints James Karis as chairman22 Jan '19
Shield Therapeutics partner starts selling iron deficiency treatment UK5 Dec '18
Shield Therapeutics iron deficiency treatment accepted by FDA for review3 Dec '18
Shield Therapeutics gets FDA confirmation of new drug application1 Oct '18
Director Deals - Shield Therapeutics Plc (STX)24 Sep '18
Broker Forecast - Peel Hunt issues a broker note on Shield Therapeutics Plc24 Sep '18
Broker Forecast - Liberum Capital issues a broker note on Shield Therapeutics Plc20 Sep '18
Shield Therapeutics posts loss; inks sales pact with Norgine19 Sep '18
Shield Therapeutics says iron deficiency treatment sales rise in Germany, UK23 Jul '18
Shield Therapeutics chairman Andrew Heat standing down5 Jun '18
Shield Therapeutics losses deepen, to cut headcount and promotional spending11 Apr '18
Shield Therapeutics to re-submit US drug application without more trials6 Apr '18
Shield Therapeutics gets extended European approval for iron-deficiency treatment27 Mar '18
Shield Therapeutics awaits FDA opinion on alteration to clinical study results16 Mar '18
Shield Therapeutics gets European nod for iron deficiency treatment23 Feb '18
Shield Therapeutics cuts costs ahead of Feraccru decision22 Feb '18
FTSE remains weak on rate concerns but US steadies5 Feb '18
FTSE hit by global sell-off5 Feb '18
Shield Therapeutics clinical trial fails to meet objectives5 Feb '18
Shield Therapeutics readies drug study10 Oct '17
Director Deals - Shield Therapeutics Plc (STX)5 Oct '17
Broker Forecast - finnCap issues a broker note on Shield Therapeutics Plc22 Sep '17
Broker Forecast - finnCap issues a broker note on Shield Therapeutics Plc7 Sep '17
Shield announces USPTO approval of 'composition of matter patent' for Feraccru6 Sep '17
Shield Therapeutics raises £12m15 Jun '17
Shield Therapeutics plans to raise c.£12m15 Jun '17
Broker Forecast - Liberum Capital issues a broker note on Shield Therapeutics Plc4 Apr '17
Shield Therapeutics P&R agreements slower than expected6 Jan '17
Broker Forecast - Canaccord Genuity issues a broker note on Shield Therapeutics Plc20 Sep '16
Shield schedules interims 15 Aug '16
Broker Forecast - Canaccord Genuity issues a broker note on Shield Therapeutics Plc18 Jul '16
Shield Therapeutics schedules FY results 23 Mar '16
Shield Therapeutics trading on AIM 26 Feb '16
Shield Therapeutics says Feraccru gets EU approval26 Feb '16
Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News



SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.